PBYI insider transaction filings
PUMA BIOTECHNOLOGY, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-16. Screen PBYI transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 5 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings by 5 insiders — 129,054 shares, $1,124,007 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 62,150 shares @ $9.12 ($566,994) by Cesano Alessandra, filed 2026-09-16.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Cesano Alessandra — Director | 1 | — | 1 leg · 62,150 sh · $566,994 | 2 |
| AUERBACH ALAN H — President and CEO, Director, 10% owner | 1 | — | 1 leg · 44,058 sh · $364,051 | — |
| NOUGUES MAXIMO F — Chief Financial Officer | 1 | — | 1 leg · 9,386 sh · $77,557 | — |
| HUNT DOUGLAS M — See Remarks | 1 | — | 1 leg · 8,460 sh · $69,905 | — |
| WILSON TROY EDWARD — Director | 1 | — | 1 leg · 5,000 sh · $45,500 | — |
Recent Form 4 filings — PUMA BIOTECHNOLOGY, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | WILSON TROY EDWARD — Director | Sale (S): 5,000 @ $9.10 | EDGAR |
| 2026-09-16 | 4 | Cesano Alessandra — Director | Option exercise (M): 50,000 @ $2.93 · Sale (S): 62,150 @ $9.12 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2026-07-08 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 8,460 @ $8.26 | EDGAR |
| 2026-07-08 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 9,386 @ $8.26 | EDGAR |
| 2026-07-08 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 44,058 @ $8.26 | EDGAR |
| 2026-06-15 | 4 | WILSON TROY EDWARD — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 10,800 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Stuglik Brian M — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 8,100 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Senderowicz Adrian — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 27,000 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Dorval Allison — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 11,610 @ $7.20 | EDGAR |
| 2026-06-15 | 4 | Cesano Alessandra — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2026-06-15 | 4 | MILLER MICHAEL PATRICK — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2026-06-15 | 4 | MOYES JAY M — Director | Grant/award (A): 27,000 @ $0 · Sale (S): 22,000 @ $7.22 | EDGAR |
| 2026-02-20 | 4 | HUNT DOUGLAS M — See Remarks | Grant/award (A): 49,394 @ $0 · Grant/award (A): 70,321 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Grant/award (A): 46,739 @ $0 · Grant/award (A): 66,541 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Grant/award (A): 159,778 @ $0 · Grant/award (A): 227,474 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 3,973 @ $5.84 · Sale (S): 5,014 @ $5.88 | EDGAR |
| 2026-01-08 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 4,540 @ $5.84 · Sale (S): 6,405 @ $5.88 | EDGAR |
| 2026-01-08 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 16,938 @ $5.84 · Sale (S): 18,012 @ $5.88 | EDGAR |
| 2025-11-13 | 4 | MILLER MICHAEL PATRICK — Director | Sale (S): 20,000 @ $4.86 | EDGAR |
| 2025-07-22 | 4 | Cesano Alessandra — Director | Sale (S): 27,000 @ $3.37 | EDGAR |
| 2025-07-10 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 5,587 @ $3.53 · Sale (S): 3,935 @ $3.54 | EDGAR |
| 2025-07-10 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 4,374 @ $3.53 · Sale (S): 3,443 @ $3.54 | EDGAR |
| 2025-07-10 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 25,592 @ $3.53 · Sale (S): 21,580 @ $3.54 | EDGAR |
| 2025-06-17 | 4 | WILSON TROY EDWARD — Director | Sale (S): 10,800 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Stuglik Brian M — Director | Sale (S): 8,100 @ $3.39 | EDGAR |
| 2025-06-17 | 4 | Senderowicz Adrian — Director | Sale (S): 27,000 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Dorval Allison — Director | Sale (S): 11,610 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | Cesano Alessandra — Director | Sale (S): 12,150 @ $3.40 | EDGAR |
| 2025-06-17 | 4 | MOYES JAY M — Director | Sale (S): 22,000 @ $3.40 | EDGAR |
| 2025-06-13 | 4 | Senderowicz Adrian — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Dorval Allison — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Stuglik Brian M — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | WILSON TROY EDWARD — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | Cesano Alessandra — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | MILLER MICHAEL PATRICK — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-06-13 | 4 | MOYES JAY M — Director | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2025-02-11 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Grant/award (A): 61,456 @ $0 · Grant/award (A): 85,067 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | Ludwig Jeffrey Jerome — Chief Commercial Officer | Grant/award (A): 47,841 @ $0 · Grant/award (A): 66,221 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | HUNT DOUGLAS M — See Remarks | Grant/award (A): 48,117 @ $0 · Grant/award (A): 66,604 (derivative) @ $0 | EDGAR |
| 2025-02-11 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Grant/award (A): 198,399 @ $0 · Grant/award (A): 274,622 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 10,227 @ $3.15 | EDGAR |
| 2025-01-03 | 4 | Ludwig Jeffrey Jerome — Chief Commercial Officer | Sale (S): 9,437 @ $3.15 | EDGAR |
| 2025-01-03 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 8,633 @ $3.15 | EDGAR |
| 2025-01-03 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 33,841 @ $3.15 | EDGAR |
| 2024-08-13 | 4 | MILLER MICHAEL PATRICK — Director | Sale (S): 23,358 @ $3.49 | EDGAR |
| 2024-07-18 | 4 | NOUGUES MAXIMO F — Chief Financial Officer | Sale (S): 4,156 @ $3.70 | EDGAR |
| 2024-07-18 | 4 | Ludwig Jeffrey Jerome — Chief Commercial Officer | Sale (S): 2,598 @ $3.70 | EDGAR |
| 2024-07-18 | 4 | HUNT DOUGLAS M — See Remarks | Sale (S): 3,637 @ $3.70 | EDGAR |
| 2024-07-18 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 21,920 @ $3.70 | EDGAR |
| 2024-07-02 | 4 | AUERBACH ALAN H — President and CEO, Director, 10% owner | Sale (S): 18,885 @ $3.27 | EDGAR |
Recent 8-K events — PUMA BIOTECHNOLOGY, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-24 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-09 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2025-05-08 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=PBYI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →